Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck (SCCHN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00662662
What this trial is testing

Sexual Behavior in Head and Neck Cancer Patients

Who this might be right for
Oropharyngeal CancerHead and Neck CancerSquamous Cell Carcinoma
M.D. Anderson Cancer Center 1,500
Not applicableStudy completedNCT03114163
What this trial is testing

Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 485
Testing effectiveness (Phase 2)Active Not RecruitingNCT02994069
What this trial is testing

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

Who this might be right for
Carcinoma, Squamous CellHead and Neck Cancer
Susanne Arnold 80
Testing effectiveness (Phase 2)Ended earlyNCT02644122
What this trial is testing

SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
Ezra Cohen 1
Testing effectiveness (Phase 2)Study completedNCT00387127
What this trial is testing

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 67
Testing effectiveness (Phase 2)WithdrawnNCT02624999
What this trial is testing

Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck

Who this might be right for
Squamous Cell Carcinoma Head and Neck
Mirror Biologics, Inc.
Early research (Phase 1)Active Not RecruitingNCT05222932
What this trial is testing

Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1

Who this might be right for
MelanomaHead and Neck Squamous Cell Carcinoma
TILT Biotherapeutics Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Study completedNCT04349267
What this trial is testing

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Bristol-Myers Squibb 44
Testing effectiveness (Phase 2)Looking for participantsNCT06526819
What this trial is testing

SMP-3124LP in Adults With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sumitomo Pharma America, Inc. 120
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Testing effectiveness (Phase 2)Study completedNCT01836029
What this trial is testing

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Celgene 195
Testing effectiveness (Phase 2)Study completedNCT02207530
What this trial is testing

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 112
Large-scale testing (Phase 3)Active Not RecruitingNCT02999087
What this trial is testing

Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 707
Not applicableStudy completedNCT05068609
What this trial is testing

Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 509
Testing effectiveness (Phase 2)Study completedNCT01612351
What this trial is testing

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Head and Neck
UNC Lineberger Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)WithdrawnNCT04595981
What this trial is testing

Chemo-embolization for Head and Neck Cancer

Who this might be right for
SCCHNSquamous Cell Carcinoma
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT02052960
What this trial is testing

CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Glycotope GmbH 240
Testing effectiveness (Phase 2)Study completedNCT01204099
What this trial is testing

Study of PX-866 and Docetaxel in Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Cascadian Therapeutics Inc. 223
Large-scale testing (Phase 3)Study completedNCT03349710
What this trial is testing

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 74
Next Page